Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying

International Journal of Pharmaceutics

Volumn 496, Issue 2, 2015, Pages 382-391

  Fong, Sophia Yui Kau ^a   Ibisogly, Asiye ^a   Bauer Brandl, Annette ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Amorphous solid dispersion; Celecoxib; Freeze drying; Solid phospholipid nanoparticles; Solubility; Spray drying

Indexed keywords

CELECOXIB; NANOPARTICLE; PHOSPHATE BUFFERED SALINE; PHOSPHOLIPID; SOLID PHOSPHOLIPID NANOPARTICLE; TREHALOSE; UNCLASSIFIED DRUG; WATER;

ARTICLE; DISPERSION; DRUG SOLUBILITY; ELECTRIC CONDUCTIVITY; FREEZE DRYING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; CHEMISTRY; COMPARATIVE STUDY; MEDICINAL CHEMISTRY; SOLUBILITY;

CELECOXIB; CHEMISTRY, PHARMACEUTICAL; FREEZE DRYING; PHOSPHOLIPIDS; SOLUBILITY; WATER;

EID: 84949595707     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.10.029     Document Type: Article

References (23)

1. O.A. Abu-Diak, D.S. Jones, and G.P. Andrews An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations Mol. Pharm. 8 2011 1362 1371
2. N.J. Babu, and A. Nangia Solubility advantage of amorphous drugs and pharmaceutical cocrystals Cryst. Growth Des. 11 2011 2662 2679
3. G.V. Betageri Enhancement of dissolution of poorly water-soluble drugs using proliposomes Am. Pharm. Rev. 11 2008
4. U. Brinkmann-Trettenes, S. Barnert, and A. Bauer-Brandl Single step bottom-up process to generate solid phospholipid nano-particles Pharm. Dev. Technol. 19 2014 326 332
5. U. Brinkmann-Trettenes, and A. Bauer-Brandl Solid phospholipid nano-particles: investigations into formulation and dissolution properties of griseofulvin Int. J. Pharm. 467 2014 42 47
6. S.T. Buckley, K.J. Frank, G. Fricker, and M. Brandl Biopharmaceutical classification of poorly soluble drugs with respect to enabling formulations Eur. J. Pharm. Sci. 50 2013 8 16
7. J.M. Butler, and J.B. Dressman The developability classification system: application of biopharmaceutics concepts to formulation development J. Pharm. Sci. 99 2010 4940 4954
8. A. Deniz, A. Sade, F. Severcan, D. Keskin, A. Tezcaner, and S. Banerjee Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics Biosci. Rep. 30 2010 365 373
9. S.A. Desobry, F.M. Netto, and T.P. Labuza Comparison of spray-drying, drum-drying and freeze-drying for β-carotene encapsulation and preservation J. Food Sci. 62 1997 1158 1162
10. R. Dontireddy, and A.M. Crean A comparative study of spray-dried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions Drug Dev. Ind. Pharm. 37 2011 1141 1149
11. S.Y.K. Fong, M. Brandl, and A. Bauer-Brandl Phospholipid-based solid drug formulations for oral bioavailbility enhancement: a meta-analysis Eur. J. Pharm. Sci. 2015 10.1016/j.ejps.2015.08.005
12. K.J. Frank Investigations into Hot Melt Extrudates: Particles, Solubility and Permeability 2012 University of Southern Denmark Odense, Denmark (PhD thesis)
13. K.J. Frank, K.M. Rosenblatt, U. Westedt, P. Hölig, J. Rosenberg, M. Mägerlein, G. Fricker, and M. Brandl Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: true supersaturation vs. apparent solubility enhancement Int. J. Pharm. 437 2012 288 293
14. K.J. Frank, U. Westedt, K.M. Rosenblatt, P. Hölig, J. Rosenberg, M. Mägerlein, M. Brandl, and G. Fricker Impact of FaSSIF on the solubility and dissolution-/permeation rate of a poorly water-soluble compound Eur. J. Pharm. Sci. 47 2012 16 20
15. G. Fricker, T. Kromp, A. Wendel, A. Blume, J. Zirkel, H. Rebmann, C. Setzer, R.O. Quinkert, F. Martin, and C. Muller-Goymann Phospholipids and lipid-based formulations in oral drug delivery Pharm. Res. 27 2010 1469 1486
16. E. Galia, E. Nicolaides, D. Horter, R. Lobenberg, C. Reppas, and J.B. Dressman Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs Pharm. Res. 15 1998 698 705
17. V.R. Gupta, S. Mutalik, M.M. Patel, and G.K. Jani Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties Acta Pharm. 57 2007 173 184
18. H. Lee, and J. Lee Dissolution enhancement of celecoxib via polymer-induced crystallization J. Cryst. Growth 374 2013 37 42
19. Y. Liu, C. Sun, Y. Hao, T. Jiang, L. Zheng, and S. Wang Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles J. Pharm. Pharm. Sci. 13 2010 589 606
20. J.M. Miller, A. Beig, R.A. Carr, J.K. Spence, and A. Dahan A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability Mol. Pharm. 9 2012 2009 2016
21. M. Morgen, C. Bloom, R. Beyerinck, A. Bello, W. Song, K. Wilkinson, R. Steenwyk, and S. Shamblin Polymeric nanoparticles for increased oral bioavailability and rapid absorption uing celecoxib as a model of a low-solubility, high-permeability drug Pharm. Res. 29 2012 427 440
22. A.A. Noyes, and W.R. Whitney The rate of solution of solid substances in their own solutions J. Am. Chem. Soc. 19 1897 930 934
23. S.K. Singh, P.R. Vuddanda, S. Singh, and A.K. Srivastava A comparison between use of spray and freeze drying techniques for preparation of solid self-microemulsifying formulation of valsartan and in vitro and in vivo evaluation BioMed. Res. Int. 2013 13 2013